バイオファーマの最新トレンドを探求し、FDAの承認から業界の変化、AI規制まで、重要なストーリー、課題、イノベーションについて議論します。
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
31 mins • May 14, 2025
Charts
- 40Increased by 49
- 184Decreased by 11
- 77Decreased by 7
- 146Decreased by 11
- 147Decreased by 7
最近のエピソード

May 14, 2025
Trump’s Drug Pricing Policy, Prasad’s CBER Nod, Bayer’s Layoffs and Galapagos’ Next Chapter
31 mins

May 8, 2025
Eroding Immunity: Vaccine Hesitancy and Cynicism
28 mins

May 7, 2025
Trump’s US Manufacturing Push, New Vaccine Policy, Novo’s Weight Loss Pill up for FDA Review
24 mins

Apr 30, 2025
Tariffs Continue to Dominate Q1 Earnings, AACR Excites Cancer Space, CEO Pay Gaps, More
24 mins

Apr 24, 2025
Economic Challenges, Strategic Investments: Reshaping the Women's Health Landscape
11 mins
